Pages that link to "Q48739266"
Jump to navigation
Jump to search
The following pages link to Feasibility, safety, and efficacy of percutaneous transhepatic injection of beta-cell grafts (Q48739266):
Displaying 12 items.
- Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation (Q30430239) (← links)
- Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation (Q33344421) (← links)
- Evaluation of wedged arterial injection as a new technique for delivery of experimental therapeutic substances into the porcine pancreas. (Q34050427) (← links)
- Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft (Q35768676) (← links)
- New therapies aimed at the preservation or restoration of beta cell function in type 1 diabetes (Q36714327) (← links)
- Hepatic hematoma after islet cell transplantation (Q37260577) (← links)
- Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients (Q37360397) (← links)
- Immune and cell therapy in type 1 diabetes: too little too late? (Q37853194) (← links)
- Early Detection of a Hepatic Artery Pseudoaneurysm After Liver Transplantation Is the Determinant of Survival. (Q38870033) (← links)
- Long-term hepatic vascular access in the nonhuman primate for recurrent portal vein infusion (Q39270682) (← links)
- Plasma GAD65, a Marker for Early β-Cell Loss After Intraportal Islet Cell Transplantation in Diabetic Patients. (Q41767345) (← links)
- Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation (Q46152226) (← links)